… therapies for Crohn’s disease (CD). Knowledge of the placebo rates of remission and response
… The aims of this study were to estimate rates of remission and response in patients with …

… potential to maintain remission in CD. The results from this meta-analysis showed that
probiotics are not more beneficial than placebo for maintaining remission and preventing clinical …

… Crohn’s disease, and studies that did not report remission as … was remission, which was
defined as a Crohn’s Disease … , we used the remission criteria defined in the study. Secondary …

… In summary, this systematic review and meta-analysis has demonstrated a modest benefit of
… a surgically induced remission, with an NNT to prevent one relapse of disease activity of 10. …

… Clinical manifestations of Crohn's disease (CD) do not reliably correlate with endoscopic …
remission (CR) has neither proven to improve CD outcomes nor alter the natural disease course…

… inducing remission or improvement in active Crohn's disease … not made available for
this study. CDAI scores were very … this study represented 33% of all patients in the meta-analysis. …

… Fecal microbiota transplantation (FMT) has been found to be a potential treatment for Crohn's
disease (CD). We sought to perform a systematic review and meta-analysis to evaluate the …

… Crohn's disease (CD), the evidence regarding its clinical benefits compared with standard
treatments (eg steroids) for maintaining remission in … ) for maintenance of remission in patients …

Background Crohn's disease (CD) is a chronic disease of the gut. About 75% of people with
CD undergo surgery at least once in their lifetime to induce remission. However, as there is …

… processes in IBD treatment. Probiotics showed therapeutic benefit in inducing remission
of UC in the present meta-analyses. We also found that maintaining remission of IBD with the …